TP53 and neuroblastoma: In consideration of the fact that less than 2% of neuroblastoma tumors harbor a mutation in TP53 at diagnosis10, it becomes reasonable to probe the p53 pathway and identify the factors that assist neuroblastoma tumors to sustain their growth potential and evade p53 pathway suppressing effects.